Repligen
RGEN
#2039
Rank
$9.33 B
Marketcap
$165.76
Share price
-0.46%
Change (1 day)
11.18%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): $26.14 Million USD

According to Repligen 's latest financial reports the company's current earnings are $0.70 Billion USD. In 2024 the company made an earning of -$6.31 Million USD a decrease over its 2023 earnings that were of $48.45 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $26.14 M-514.69%
2024 -$6.31 Million-113.01%
2023 $48.45 M-78.01%
2022 $0.22 B33.37%
2021 $0.16 B131.52%
2020 $71.35 M101.31%
2019 $35.44 M25.93%
2018 $28.14 M105.61%
2017 $13.68 M-11.46%
2016 $15.46 M14.91%
2015 $13.45 M20.26%
2014 $11.18 M-51.49%
2013 $23.06 M90.98%
2012 $12.07 M
2010 $0.17 M-103.81%
2009 -$4.59 Million-223.84%
2008 $3.7 M
2006 -$2.49 Million229.64%
2005 -$0.76 Million-89.16%
2004 -$6.97 Million-16.86%
2003 -$8.38 Million88.72%
2002 -$4.44 Million-27.88%
2001 -$6.16 Million-1.74%
2000 -$6.27 Million85.93%
1999 -$3.37 Million159.16%
1998 -$1.3 Million85.71%
1997 -$0.7 Million-70.83%
1996 -$2.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novavax
NVAX
$0.37 B 1,334.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.67 B 2,498.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$0.58 B 2,130.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$10.25 B 39,143.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$7.09 B 27,044.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$8.03 B 30,628.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$11.85 B 45,237.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$0.11 B 342.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-$0.11 Billion-517.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-$22.2 Million-184.90%๐Ÿ‡บ๐Ÿ‡ธ USA